South San Francisco Newswire

Comprehensive Real-Time News Feed for South San Francisco, CA.

Results 1 - 20 of 28 for "u:freshnews.com" in South San Francisco, CA

  1. Compugen Expands and Strengthens Business Development TeamRead the original story

    Monday Feb 23 | Freshnews

    Compugen Ltd. today announced the appointment of Dr. Felix Karim as Vice President Corporate & Business Development, effective March 2, 2015. Dr. Karim, who will be based at Compugen's South San Francisco facilities, will report to Dr. Anat Cohen-Dayag, Compugen's President and Chief Executive Officer, and will have direct responsibility for the Company's business development strategy and its execution.

    Comment?

  2. Compugen Ltd. Reports Fourth Quarter and Calendar 2014 ResultsRead the original story

    Tuesday Feb 10 | Freshnews

    Anat Cohen-Dayag, PhD, President and CEO of Compugen, stated, "A number of achievements last year resulted in a significant increase in our corporate strength and confidence. In particular, the promising data of our early stage immuno-oncology candidates, the achievement of two milestones in our joint preclinical work under the Bayer collaboration, the substantial increase in our throughput capabilities and expertise, and the availability of substantial additional capital, have allowed us to begin 2015 with much greater opportunities for accelerated growth.

    Comment?

  3. Compugen to Present Cancer Immunotherapy Targets at Two Tumor Immunology Conferences This MonthRead the original story

    Monday Feb 2 | Freshnews

    Compugen Ltd. today announced that it will present aspects of its immune checkpoint related research at two scientific conferences this month. On February 9, Arthur Machlenkin, PhD, Head of Immunology Group at Compugen, will deliver an oral presentation at the Keystone Symposia: Tumor Immunology - Multidisciplinary Science Driving Combination Therapy being held from February 8-13, in Banff, Canada.

    Comment?

  4. Theravance Biopharma Announces New Employment Inducement AwardsRead the original story

    Jan 5, 2015 | Freshnews

    The options were granted in accordance with NASDAQ Listing Rule 5635 under the Theravance Biopharma, Inc. 2014 New Employee Equity Incentive Plan , which the Board of Directors of Theravance Biopharma adopted in October 2014 to facilitate the granting of equity awards to new employees. Each option has an exercise price per share equal to $14.70, which was the closing price of one Theravance Biopharma ordinary share on the Nasdaq Global Market on the date of grant.

    Comment?

  5. FDA Approves GazyvaA (Obinutuzumab) Supplemental Biologics License...Read the original story

    Dec 24, 2014 | Freshnews

    SOUTH SAN FRANCISCO, Calif. -- -- Genentech, a member of the Roche Group , today announced that the U.S. Food and Drug Administration approved a supplemental biologics license application for Gazyva in combination with chlorambucil chemotherapy in people with previously untreated chronic lymphocytic leukemia .

    Comment?

  6. Linkage Biosciences Announces ExpansionRead the original story

    Dec 22, 2014 | Freshnews

    "We're pleased Linkage Biosciences has chosen to continue to grow in South San Francisco," said South San Francisco Mayor Richard Garbarino. "We hope that they will grow in our City for many more years.

    Comment?

  7. Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc....Read the original story

    Dec 17, 2014 | Freshnews

    Tigercat Pharma, Inc. today announced positive results of a Phase 2 study evaluating the investigational oral NK-1 receptor antagonist VPD-737 , for the treatment of patients with severe, chronic itch who are unresponsive or inadequately responsive to the current standard of care, including topical steroids and antihistamines. The primary efficacy endpoint was percent change in Visual Analog Scale itch score from baseline, comparing drug to placebo for each dose group.

    Comment?

  8. California Healthcare Institute and Bay Area Bioscience Association...Read the original story

    Dec 8, 2014 | Freshnews

    PALO ALTO, Calif. & SAN DIEGO -- -- The California Healthcare Institute , a nonprofit, public policy research organization representing leading California academic institutions, biotechnology, medical device, diagnostics and pharmaceutical firms, and the Bay Area Bioscience Association , the association for the Northern California life science community, today announced that the two organizations have signed a letter of intent to merge their operations into a newly created organization, to be called the California Biomedical Innovation Alliance , representing the entire biomedical ecosystem of the state of California in one organization.

    Comment?

  9. Theravance Biopharma Announces New Employment Inducement AwardsRead the original story

    Dec 3, 2014 | Freshnews

    Theravance Biopharma, Inc. announced today, through its U.S. operating subsidiary, Theravance Biopharma US, Inc., that stock options to purchase an aggregate of 104,800 of the Company's ordinary shares were granted to ten new non-executive officer employees on December 1, 2014. The options were granted in accordance with NASDAQ Listing Rule 5635 under the Theravance Biopharma, Inc. 2014 New Employee Equity Incentive Plan , which the Board of Directors of Theravance Biopharma adopted in October 2014 to facilitate the granting of equity awards to new employees.

    Comment?

  10. Compugen to Present at Oppenheimer 25th Annual Healthcare ConferenceRead the original story

    Dec 3, 2014 | Freshnews

    Compugen Ltd. today announced that Anat Cohen-Dayag, Ph.D., President and Chief Executive Office of Compugen, will present a company overview at the Oppenheimer 25th Annual Healthcare Conference in New York on Wednesday, December 10 at 2:10 p.m. ET. Compugen is a leading drug discovery company focused on therapeutic proteins and monoclonal antibodies to address important unmet needs in the fields of oncology and immunology.

    Comment?

  11. Theravance Biopharma to Host Investor and Analyst Day on December 12thRead the original story

    Nov 20, 2014 | Freshnews

    Theravance Biopharma, Inc. announced today, through its U.S. operating subsidiary, Theravance Biopharma US, Inc., that the Company will host an Investor and Analyst Day for the investment community on Friday, December 12, 2014 from 8:30 am to 11:30 am EST in New York, NY. Management will present updates regarding the post-split business outlook, commercial strategy for VIBATIV , and key development programs.

    Comment?

  12. Theravance Biopharma to Present at the Stifel Healthcare Conference on November 18thRead the original story

    Nov 12, 2014 | Freshnews

    Theravance Biopharma, Inc. announced today, through its U.S. operating subsidiary, Theravance Biopharma US, Inc., that Rick E Winningham, Theravance Biopharma's chief executive officer, is scheduled to present at the Stifel Healthcare Conference on Tuesday, November 18, 2014, at 9:45 a.m. EST. The conference will be held from November 18-19 in New York at the New York Palace Hotel.

    Comment?

  13. Compugen to Present at Jefferies 2014 Global Healthcare Conference in LondonRead the original story

    Nov 12, 2014 | Freshnews

    Compugen Ltd. today announced that Dr. Anat Cohen-Dayag, President and Chief Executive Officer of Compugen, will present a corporate overview and update at the Jefferies 2014 Global Healthcare Conference in London, UK. The Compugen presentation is scheduled to start at 10:40 a.m. GMT on Thursday, November 20, 2014.

    Comment?

  14. NASA Signs Lease with Planetary Ventures LLC for Use of Moffett...Read the original story

    Nov 10, 2014 | Freshnews

    In an effort to reduce costs and shed surplus property, NASA today signed a lease with Planetary Ventures, LLC to manage Moffett Federal Airfield , an agency facility located in Moffett Field, California, and rehabilitate its historic Hangar One. NASA estimates the lease will save the agency approximately $6.3 million annually in maintenance and operation costs and provide $1.16 billion in rent over the initial 60-year lease term.

    Comment?

  15. Compugen Third Quarter 2014 Conference Call Scheduled for Wednesday, October 29, 2014 at 10:00 Am EtRead the original story

    Oct 22, 2014 | Freshnews

    Compugen Ltd. today announced that the Company will host a conference call at 10:00 AM ET on Wednesday, October 29, 2014 to review third quarter 2014 results. The quarterly results will be released on the Company's website , prior to the conference call.

    Comment?

  16. FDA Approves EsbrietA (pirfenidone) for the Treatment of Idiopathic...Read the original story

    Oct 15, 2014 | Freshnews

    SOUTH SAN FRANCISCO, Calif. -- -- Genentech, a member of the Roche Group , today announced that the U.S. Food and Drug Administration has approved Esbriet as a treatment for idiopathic pulmonary fibrosis in the United States.

    Comment?

  17. BioMed Realty Launches New Mobile Application To Provide An Immersive ...Read the original story

    Oct 13, 2014 | Freshnews

    BioMed Realty Trust, Inc. today became the first life science real estate company to launch a mobile application on the Apple platform that provides tenants and brokers with an immersive introduction to the company's four new development opportunities in Boston/Cambridge, San Francisco, San Diego and Seattle. The new application is now available for free download on iPhones and iPads from Apple's App Store.

    Comment?

  18. Correcting and Replacing Emd Serono and Sutro Biopharma to Partner on ...Read the original story

    Sep 17, 2014 | Freshnews

    Sixth paragraph, second sentence of release should read: Sutro is also eligible to receive payments on completion of certain research, development and regulatory milestones potentially totaling approximately $298 million as well as royalties on product sales. . Sutro's Xpress CF and Xpress CF+ platforms to be utilized to develop antibody drug conjugates for multiple undisclosed targets EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, and Sutro Biopharma, San Francisco, a biopharmaceutical company developing antibody drug conjugates and bispecific antibodies, today announced a collaboration and license agreement to develop antibody drug conjugates .

    Comment?

  19. Bay Area BioEconomy Initiative Appoints Onyx Pharmaceuticals...Read the original story

    Sep 10, 2014 | Freshnews

    The Bay Area BioEconomy Initiative today announced that it has named Pablo J. Cagnoni, M.D., President of Onyx Pharmaceuticals, Inc., to its Steering Committee. Onyx, an Amgen subsidiary, is engaged in the development and commercialization of innovative therapies to improve the lives of people with cancer.

    Comment?

  20. Preventice and eCardio Diagnostics Announce Strategic Combination in...Read the original story

    Sep 9, 2014 | Freshnews

    Preventice, developer of the PatientCare Platform and the BodyGuardian Remote Monitoring Sensor and an innovator in software solutions for remote patient care, and eCardio Diagnostics LLC , a leading provider of remote cardiac monitoring products and services, announced today a strategic combination of Preventice and eCardio to drive innovation and growth in remote monitoring systems and mobile health applications.

    Comment?

South San Francisco Job Listings
View or post South San Francisco job listings on Topix.
South San Francisco Real Estate
News, listings, and foreclosures in South San Francisco from Topix.
South San Francisco Mortgages
Find mortgage rates in South San Francisco on Topix.